RNAi gene therapy of SiHa cells via targeting human TERT induces growth inhibition and enhances radiosensitivity

26Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Telomerase activity (TA) is reactivated in more than 90% of all human malignant tumors and normal somatic cells that lack TA. Thus, human TERT (hTERT) is a promising target in malignant tumor treatment. RNA interference is a powerful tool for gene silencing. In this study, we constructed siRNA#1-4 to knock down hTERT. All siRNAs were able to downregulate hTERT differently and we chose siRNA#3 (most effectively) in the following experiments. We studied the effects on cell proliferation, cell cycle, cell apoptosis and radiosensitivity using SiHa cells. Our results showed that siRNA#3 was able to silence hTERT gene effectively. The silencing of hTERT could induce immediate growth arrest, enhance the S phase in cell cycle study and lead to early apoptosis in human cervical cancer cells (SiHa). In clonogenic assays, we used multitarget-single hit and linear-quadratic models to assess the radiosensitivity after knockdown of hTERT. All results of parameters (D0, Dq, , β) indicated that downregulation of hTERT enhanced radiosensitivity in SiHa cells.

Cite

CITATION STYLE

APA

Zhang, W., & Xing, L. (2013). RNAi gene therapy of SiHa cells via targeting human TERT induces growth inhibition and enhances radiosensitivity. International Journal of Oncology, 43(4), 1228–1234. https://doi.org/10.3892/ijo.2013.2051

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free